Investor Stock List
Ranked #3,382 of 8,699 institutional investors

Eagle Health Investments LP

Greenwich, CT

$561M
US stock portfolio at live prices · today −$4.1M (−0.72%)
Live prices, last trade 12:37 PM ET
Value at quarter end (Q3 2026)
$582M
Change from Q2 2026
−$21.6M (−3.57%)
Positions
18 · 3 new, 7 sold out
Filed
Nov 13, 2026

Not counted in the ranking: put options on $26.8M. $116M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
ARGX 12.8%INSM 9.29%UTHR 7.89%ISRG 7.83%GH 7.81%
StockSharesValue, live% of portfoliovs Q2 2026
ARGX argenx SE76,593$72.0M12.8%Added +0%
INSM Insmed Incorporated358,702$52.1M9.29%Reduced −7%
UTHR United Therapeutics Corporation79,678$44.3M7.89%New
ISRG Intuitive Surgical, Inc.108,546$43.9M7.83%Added +2,373%
GH Guardant Health, Inc.300,685$43.8M7.81%Unchanged
PTGX Protagonist Therapeutics, Inc.248,322$30.4M5.43%Unchanged
SRRK Scholar Rock Holding Corporation561,527$28.3M5.04%Added +1%
FTRE Fortrea Holdings Inc.1,181,274$22.5M4.01%Unchanged
BSX Boston Scientific Corporation459,114$19.6M3.49%Added +24%
RVMD Revolution Medicines, Inc.120,346$19.5M3.47%Unchanged
CMPS COMPASS Pathways plc2,060,427$16.7M2.98%Unchanged
KYMR Kymera Therapeutics, Inc.119,268$13.8M2.46%Reduced −28%
REPL Replimune Group, Inc.724,787$13.8M2.46%New
DNTH Dianthus Therapeutics, Inc.131,344$11.1M1.98%Unchanged
AXSM Axsome Therapeutics, Inc.65,051$8.5M1.52%Unchanged
AVTX Avalo Therapeutics, Inc.235,093$1.6M0.28%Unchanged
SMMT Summit Therapeutics Inc.154,493$1.5M0.28%New
IMCR Immunocore Holdings plc46,300$1.2M0.22%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
BMRN BioMarin Pharmaceutical Inc.624,676$38.1M
ILMN Illumina, Inc.187,413$36.4M
RARE Ultragenyx Pharmaceutical Inc.884,121$14.6M
TEM Tempus AI, Inc.256,269$14.3M
IONS Ionis Pharmaceuticals, Inc.194,577$5.4M
NTRA Natera, Inc.15,847$4.4M
LLY Eli Lilly and Company1,994$2.7M